We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Sensor Technology Diagnoses Reproductive Health Issues

By HospiMedica International staff writers
Posted on 07 Mar 2019
New robotic sensors can measure hormones that affect fertility, sexual development, and menstruation in real-time and at less cost than current methods.

Developed by researchers at Imperial College London (Imperial; United Kingdom) and the University of Hong Kong (China), the Robotic APTamer-enabled Electrochemical Reader (RAPTER) electrochemical analysis system is designed to assess reproductive functioning by measuring the pulsatile secretion of luteinizing hormone (LH). More...
RAPTER uses an electrochemical aptamer-based 96-well-plate sensing platform that identifies DNA aptamers that bind specifically to LH, and not related hormones.

In a study involving 441 blood samples of women who either had normal reproductive function, were menopausal, or had hypothalamic amenorrhea, the low-cost RAPTER platform was able to instantly detect changes in LH pulse patterns using Bayesian spectrum analysis, distinguishing between women with menopause who have high LH levels, healthy fertile women with normal LH levels, and women with hypothalamic amenorrhea who have low LH levels. The study was published on February 20, 2019, in Nature Communications.

“We have developed technology that is able to measure LH pulsatility in patients more quickly and cheaply than current methods,” said senior author Professor Tony Cass, PhD, of the Imperial College London chemistry department. “We will now work towards making the technology more accessible for the clinic by reducing the size of the device, which could revolutionize the clinical care of patients with reproductive or other disorders.”

“The detection methodology that we have developed for LH sensing is widely applicable for real-time monitoring of all kinds of biomolecules that relate to health and wellbeing. It could also be developed to monitor other hormones, such as cortisol,” said senior author Julian Tanner, MD, of the University of Hong Kong. “Excitingly, with further research, this technology could be adapted for implanted sensors that could transform health monitoring in all kinds of contexts.”

Reproductive function is governed by a highly orchestrated pattern of hormonal feedback across the hypothalamic–pituitary–gonadal axis, with the pulsatile release of LH compromising a critical element of downstream regulation of sex steroid hormone synthesis, and the production of mature oocytes. Levels of LH and altered patterns of LH pulse secretion have been linked to hypothalamic dysfunction, resulting in numerous reproductive disorders, including polycystic ovary syndrome, hypothalamic amenorrhea, and delayed or precocious puberty.

Related Links:
Imperial College London
University of Hong Kong


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.